Could uric acid have a role in acute renal failure?

被引:176
作者
Ejaz, A. Ahsan
Mu, Wei
Kang, Duk-Hee
Roncal, Carlos
Sautin, Yuri Y.
Henderson, George
Tabah-Fisch, Isabelle
Keller, Birgit
Beaver, Thomas M.
Nakagawa, Takahiko
Johnson, Richard J.
机构
[1] Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA
[2] Univ Florida, Div Thorac & Cardiovasc Surg, Gainesville, FL 32610 USA
[3] Ewha Womans Univ, Div Nephrol, Seoul, South Korea
[4] Sanofi Aventis, Paris, France
[5] Accovion, Eschborn, Germany
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 01期
关键词
D O I
10.2215/CJN.00350106
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Acute renal failure (ARF), induced by either toxins or ischemia, is associated with significant morbidity. The pathogenesis of ARF is complex and is characterized by renal vasoconstriction and oxidative stress in association with tubular and microvascular injury and interstitial inflammation. In many situations, ARF is associated with a rise in serum uric acid as a result of both increased generation and decreased excretion. Although it is widely recognized that markedly elevated levels of uric acid can cause ARF via supersaturation within the tubules with crystallization and intrarenal obstruction ("acute urate nephropathy"), the possibility that uric acid may affect renal outcomes at concentrations that do not lead to tubular obstruction have not been considered. This article reviews both the salutary and the adverse effects of uric acid on biologic processes and presents the hypothesis that hyperuricemia, particularly if chronic and marked, likely represents a true risk factor for ARF. Hyperuricemia also may account for the paradoxic lack of benefit of diuretics in the management of ARF. It is suggested that studies are needed to investigate the role of chronic hyperuricemia on renal outcomes after acute tubular injury.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 58 条
[1]
URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].
AMES, BN ;
CATHCART, R ;
SCHWIERS, E ;
HOCHSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862
[2]
RENAL-FUNCTION DURING CARDIOPULMONARY BYPASS - INFLUENCE OF PUMP FLOW AND SYSTEMIC BLOOD-PRESSURE [J].
ANDERSSON, LG ;
BRATTEBY, LE ;
EKROTH, R ;
HALLHAGEN, S ;
JOACHIMSSON, PO ;
VANDERLINDEN, J ;
WESSLEN, O .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (11) :597-602
[3]
Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy [J].
Basile, DP .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (01) :1-7
[4]
Recent advances in the pathophysiology of ischemic acute renal failure [J].
Bonventre, JV ;
Weinberg, JM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (08) :2199-2210
[5]
Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells [J].
Brodsky, SV ;
Yamamoto, T ;
Tada, T ;
Kim, B ;
Chen, J ;
Kajiya, F ;
Goligorsky, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 282 (06) :F1140-F1149
[6]
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[7]
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Quyyumi, AA ;
Panza, JA .
HYPERTENSION, 1997, 30 (01) :57-63
[8]
Chertow GM, 1997, CIRCULATION, V95, P878
[9]
ACUTE RENAL-FAILURE - IMPORTANT COMPLICATION OF CARDIAC-SURGERY IN INFANTS [J].
CHESNEY, RW ;
KAPLAN, BS ;
FREEDOM, RM ;
HALLER, JA ;
DRUMMOND, KN .
JOURNAL OF PEDIATRICS, 1975, 87 (03) :381-388
[10]
COGHLAN JG, 1994, J THORAC CARDIOV SUR, V107, P248